Seeking Alpha

Savient Pharmaceuticals misses by $0.04

  • Savient Pharmaceuticals (SVNT): Q2 EPS of -$0.35 misses by $0.04.
  • Revenue of $6.7M (+44% Y/Y). (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)